Form 8-K Verrica Pharmaceuticals For: May 13
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Verrica Pharmaceuticals (VRCA) PT Raised to $12 at Jefferies
May 14, 2024 9:35 AM EDTJefferies analyst Glen Santangelo raised the price target on Verrica Pharmaceuticals (NASDAQ: VRCA) to $12.00 (from $10.00) while maintaining a Buy rating.
The analyst comments "Updating model to reflect 1Q results. Overall, we remain encouraged with the launch and continue to see opportunity for... More
